Michael Warner
Family Medicine · West Chester, PANPI 1437266137
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,558 and has fallen 98.9% since, to $17 in 2024.
Across 111 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$219
- AstraZeneca$214
- GSK$163
- Amgen$162
- Amarin Pharma, Inc.$151
- Johnson & Johnson$110
- plus $656 from 16 others
What the payments were for
- Food & beverage$1,62697%
- Education$483%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 16 | $219 |
| AstraZeneca | 11 | $214 |
| GSK | 12 | $163 |
| Amgen | 11 | $162 |
| Amarin Pharma, Inc. | 14 | $151 |
| Johnson & Johnson | 8 | $110 |
| Biohaven Pharmaceuticals, Inc. | 1 | $100 |
| Novartis | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 4 | $57 |
| Boehringer Ingelheim | 4 | $54 |
| Astellas Pharma US Inc | 3 | $51 |
| Pfizer | 3 | $43 |
| Merck | 3 | $41 |
| Lilly USA, LLC | 3 | $40 |
| AbbVie | 3 | $38 |
| Teva Pharmaceuticals USA, Inc. | 3 | $37 |
| Hikma Pharmaceuticals USA | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Shire North American Group Inc | 1 | $23 |
| Genentech USA, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
How this compares
$1,674 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Armodafinil | 11 | $1,093 |
| Gabapentin | 11 | $587 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $397 |
| Morphine Sulfate ErMorphine Sulfate | 14 | $373 |
| Oxycodone Hcl | 27 | $348 |
| Celecoxib | 11 | $177 |
| Levothyroxine Sodium | 19 | $63 |
| Zolpidem Tartrate | 12 | $33 |
| Tamsulosin Hcl | 11 | $28 |
| Cyclobenzaprine Hcl | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Other family medicine in West Chester
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.